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a b s t r a c t
On entry into the body herpes simplex viruses (HSV) replicate in a series of steps that involves derepression
of viral DNA activated by VP16, a virion protein, and sequential transcription of viral genes in a cascade
fashion. HSV also enters into neurons in which viral DNA maintained as heterochromatin and with few
exceptions viral gene expression is silenced. A third face of the interaction of HSV with its host cells takes
place at the moment when the silenced viral genome in neurons is abruptly derepressed. The available
data do no reveal evidence that HSV encodes different regulatory programs for each facet of its interaction
with its host cells. Rather the data point to signiﬁcant gaps in our knowledge of the mechanisms by which
each facet is initiated and the roles of the infected cells at each facet of the interaction of viral gene
products with the host cell.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
If herpes simplex viruses (HSV) could unveil their moto, it would
read “Multiply, Persist and Disseminate”. Indeed for more than a
century it has been recognized that HSV infect people by direct contact
between tissues of individuals with a herpetic lesion and those of a
healthy individual. In the course of multiplication at the portal of entry
the virus infects nerve endings and is transported to a dorsal root or
sensory neuron where it remains quasi-silent or, in the traditional
terminology, latent. In some individuals the virus remains latent for a
life time. In others it periodically replicates and is transported
anterograde to a site at or near the portal of entry into the body
where it replicates and is transmissible by contact (reviewed in
Roizman et al., 2013. That HSV is successful in its endeavor to replicate,
persist and disseminate is evident from the fact that in many
populations the incidence of HSV-1 infections approaches 100%.This
extraordinary achievement is due in large part to the exceptional
control of viral gene expression during initial replication at the portal
of entry, In the course of latent infection and even in the course of
reactivation from latent state. In every sense of the word, HSV is a
control freak. It is convenient to consider each of the 3 states of HSV
sojourn in human bodies separately.
Productive infection at the portal of entry
Viral replication at the portal of entry into the body is a
multicycle event that ultimately becomes arrested by the immune
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system. The accepted model of the events that take place in the
course of a single replicative cycle is the cell culture in which most
if not all cells can be synchronously infected. Current understan-
ding of the events taking place in the infected cell may be
summarized as follows:
On infection HSV brings into the cells a capsid containing DNA
and approximately 20 proteins packaged in the tegument—a com-
partment located between the capsid and envelope (Roizman and
Furlong, 1974). The capsid is transported to the nuclear pore where
it releases the viral DNA into the nucleoplasm. Among tegument
proteins 3, i.e. the virion host shutoff (VHS) RNase, VP16 and UL47
are also translocated to the nucleus (Shu et al., 2013)
On entry of viral DNA into the nucleus several interrelated events
take place. Foremost, DNA sensors trigger innate immune responses.
A key component of the response is the induction of numerous stress
response mRNAs that are degraded by VHS (Esclatine et al., 2004). A
second event with signiﬁcant consequences is the assembly at viral
DNA of a dynamic structure designated formally as ND10 or PML
bodies and regulated by the promyelocytic leukemia (PML) protein
(Ishov and Maul 1996, Maul et al., 1993, 1996). A third key event is
insertion of repressive modiﬁcations that preclude the expression of
viral genes (Bryant et al., 2011, Cliffe et al., 2009; Knipe and Cliffe,
2008; Kristie, 2007; Huang et al., 2006; Liang et al., 2009; Silva et al.,
2008; Narayanan et al., 2007).
The order of expression of viral genes. The α genes
The earliest studies focused on the order of viral gene expression in
productive infection. Thus studies on the inhibitors of protein synth-
esis identiﬁed 5 genes expressed after infection in the absence of de
novo protein synthesis. The products of these genes were designated
as Infected Cell Proteins (ICPs) 0, 4, 22, 27, and 47 on the basis of their
migration on electrophoresis in denaturing gels (Honess and Roizman,
1974, 1975). A second, much larger group of ICPs accumulated in
infected cells treated with phosphonocetate, an inhibitor of viral DNA
synthesis. Lastly, the early studies identiﬁed a larger group of ICPs that
accumulated in infected cells in the absence of inhibitors (Honess and
Roizman, 1974, 1975). In principle these groups corresponded to
immediate-early, early and late nomenclature adapted from bacter-
iophage. The subdivisions however were more complex. Among the
early protein some, (e.g. ICP8) are made very early whereas others (e.g.
the thymidine kinase) are made much later. Among the late proteins
some aremade in small amounts in the absence of viral DNA synthesis
whereas others required de novo synthesis of viral DNA in order to
accumulate in infected cells. To avoid a complicated nomenclature that
described these diverse groups as immediate-early, early-early, early-
late, late-early and late-late they were designated as α, β1, β2, γ1,and γ2,
respectively. The complexity of requirements for the sequential
synthesis of viral gene products did not rest there. In recent studies
it was shown that only ICP0 was made in cells depleted of the histone
acetyl transferase CLOCK (Kalamvoki and Roizman 2010). In essence,
these studies revealed that ICP0 recruits Bmal1 which in turn recruits
its partner CLOCK to the viral transcriptome. This enables the
transcription of other α genes.
Finally there is evidence that the expression of some open reading
frames (e.g. ORF P and ORF O) is blocked by α proteins as are some
miRNAs that accumulate preferentially in cells exposed to inhibitors
of protein synthesis at the time of infection (Randall et al., 1997; Du
et al., 2015).
The fundamental principle guiding the early studies on productive
infections is that on entry of viral DNA into the nucleus the
expression of viral genes is sequentially ordered (activated) in a
cascade fashion. In quick succession α gene promoters were found to
share common sequences (5 G/CTAATGAG/AATTCC/TTTGNGGG3')
containing binding sites for Oct1 and VP16, a viral structural protein
brought into cells along with viral DNA and a cellular protein
designated Host Cell Factor 1 (HCF1). (Mackem and Roizman, 1982,
Pellett et al., 1985, Kristie and Roizman, 1987, McKnight et al., 1987,
Kristie and Roizman, 1988) Elegant, compelling studies have shown
that VP16 enables the assembly of Oct1, HCF1 and lysine speciﬁc
demethylase 1 (LSD1) along with transcriptional factors to derepress
and initiate the transcription of α genes (Liang et al., 2009). LSD1
plays a key role in the derepression of α genes. In uninfected cells the
protein is unstable in the absence of its partner (CoREST) (Shi et al.,
2005, Yang et al., 2006). The available data suggest that LSD1 is
recruited by VP16 from its partner (Zhou et al., 2010). Once ICP0 is
made, additional proteins (e.g. CD4, CLOCK, etc) are recruited to
enhance genes expression (Kalamvoki and Roizman 2010).
All α gene promoters contain the response elements required
for the binding of the VP16/Oct1/HCF1/LSD1 complex(Mackem
and Roizman, 1982, Pellett et al., 1985, Kristie and Roizman, 1987,
McKnight et al., 1987, Kristie and Roizman, 1988) and hence they
are predicted to be derepressed. At the same time the observation
that the synthesis of ICP4, ICP22, ICP27, and ICP47 but not that of
ICP0 depends on the recruitment of CLOCK (Kalamvoki and
Roizman 2010) suggests that the interactions of ICP4, ICP22, IC27
and ICP47 promoters with the VP16/Oct1/HCF1/LSD1 complex are
necessary but not sufﬁcient for their expression. The data also
predict that there may be some fundamental differences in the
response elements present in the promoter of ICP0 as compared to
those of other α genes.
Expression of β and γ genes
The promoters of β and γ genes lack the response elements for
binding of VP16/Oct1/HCF1/LSD1 complex. Numerous studies, too nu-
merous to cite here, focused on ﬁnding group-speciﬁc response
elements in β and γ genes to no avail (Reviewed in Roizman et al.,
2013). The available data again, too numerous to cite here, indicate
that derepression of α genes does not ipso facto result in the
expression of all viral genes. Numerous studies have pointed to ICP0
as the key element necessary but not sufﬁcient for the expression of all
viral genes.
ICP0 is the epitome of a multifunctional protein. It binds numer-
ous proteins and performs multiple functions throughout the repli-
cative cycle of the virus (Reviewed in Roizman et al., 2013). It resides
in the nucleus during the ﬁrst 6 to 7 h after infection and then
mysteriously disappears from the nucleus and appears in the
cytoplasm. The duration of the sojourn in the nucleus is depended
on the amount of DNA introduced into the cells along with the virus
(Lopez et al., 2001; Kalamvoki and Roizman, 2008). Relevant to the
expression of β and γ genes are two functions. In the order of
discovery, ICP0 acts as an E3 ubiquitin ligase. In combinationwith the
UbCH5A ubiquitin conjugating enzyme it degrades PML and SP100.
(Boutell et al., 2002, Gu and Roizman, 2003) A consequence of the
degradation of PML and SP100 is the dispersal of the constituents of
the ND10 bodies). What remains in their place are host and viral
proteins recruited by α proteins. They form the nucleus of the
replication compartments in which viral DNA is transcribed and
replicated (Reviewed in Roizman et al., 2013). The second function of
ICP0 is to bind CoREST and displace HDAC1 or 2 from to HDAC/
CoREST/LSD1/REST (HCLR) complex (Gu et al., 2005, Gu and
Roizman, 2007). The known functions of the HCLR complex are to
repress neuronal genes in non-neuronal cells (Ballas and Mandel,
2005). REST is a highly postranslationally modiﬁed protein with
repressor binding sits at both ends of the protein. It binds a some-
what degenerate response element (RE1). On displacement of HDAC1
by ICP0 the complex falls apart and its components are translocated
to the cytoplasm (Gu et al., 2005, Gu and Roizman, 2007)
Both degradation of PML and disassembly of HCLR complex
have been linked to the derepression and expression of β and γ
genes and their functions are not clearly separable (Lopez et al.,
B. Roizman, G. Zhou / Virology 479-480 (2015) 562–567 563
2002, Du et al., 2010, Gu and Roizman, 2009, Everett et al., 2006).
Nevertheless three studies show considerable light on the two
cited functions of ICP0.
Thus, overexpression of PML precluded the dispersal of ND10
bodies but had no effect on accumulation of infectious virus or its
proteins (Lopez et al., 2002). Next, this laboratory constructed a
dominant negative (dn) CoREST in which the binding site for HDAC1
was deleted. A recombinant virus in which ICP0 was replaced by the
dnCoREST replicated 10 to 100 fold higher yields than the ICP0 null
mutant in a cell type dependent manner (Du et al., 2010). These and
other studies (Zhou et al., 2010) implied that displacement of the HCLR
complex is a key requirement for the expression of β and γ genes (Du
et al., 2010, Zhou et al., 2010). Lastly, another key ﬁnding stemmed
from comparisons of the replication of wild-type and ΔICP0 mutant
virus in murine wild type (PMLþ/þ) and PML/ cells. Speciﬁcally
the wild-type and ΔICP0 mutant each replicated equally well in both
cell lines. The difference emerged on pretreatment of the cell lines
with interferon α or γ. Interferon pretreatment had little or no effect on
or the replication of both viruses in PML/ cells but had a very
signiﬁcant effect on the growth of the two viruses in PLMþ/þ cells
(Chee et al., 2003). The results suggest that PML acts s regulator of
antiviral effects of interferon. In the absence of interferon, the two cell
lines were to the extent tested indistinguishable. If degradation of PML
were the key requirement for the expression of β and γ genes we could
have expected higher yields for ΔICP0 mutant in PML/ cells.
Conclusions
The fundamental conclusions of the early studies were that α
proteins perform multiple functions that result in the recruitment to
the viral transcriptome critical components necessary for effective
transcription as well as in preemptive degradation of cellular defense
mechanisms-functions not covered in this review. The fundamental
conclusions of the past decade are that (a) viral genes are repressed on
entry of viral DNA into the nucleus, (b) viral genes form clusters that
are sequentially derepressed and (c) the identity of the key players has
been revealed. We are faced, however with enormous gaps. Although
promoter substitutions revealed that the sequences conferring γ2
speciﬁcity resides in the 5' transcribed noncoding domain down-
stream of the TATA box (Mavromara-Nazos and Roizman, 1989), we
have no cohesive pictures for the differential expression of β and
γ2 genes.
We are also confronted with a puzzle. Derepression of viral genes
by dnCoREST implies the presence of numerous REST response
elements in the viral DNA. We estimated as many as 30 based on a
somewhat liberal interpretation of the somewhat degenerate REST
binding site (G. Zhou and B. Roizman, unpublished studies). Implicit
in such a scheme is that the virus evolved rather then attempted to
rid itself of repressive sites. What would be the purpose of a vast
layer or repressive sites that could interfere with viral replication?
Expression of viral genes in the latent state
Although latent HSV infections have been established in marmo-
sets, Aotus monkeys, guinea pigs, and rabbits the most common
model is the mouse. Mice are commonly inoculated by the skin,
corneal or vaginal routes. After 4 weeks all traces of infectious virus
disappear. Infectious virus can be recovered by explantation in cult-
ure of sensory ganglia innervating the site of inoculation of the virus
(Reviewed in Roizman et al., 2013). The mouse model presents
numerous advantages for the study of the latent sate. Speciﬁcally,
while trace amounts of mRNAs of various viral genes have been
detected during the latent state, there are no frequent spontaneous
reactivation of latent virus to complicate analyses of viral gene
expression during latency (Margolis et al., 2007). One confounding
issue does exist: in the mouse HSV replicates in the ganglia after
inoculation. Following corneal inoculation replicating virus can be
detected in ganglia within 24 h after inoculation. The virus reaches
peak levels sometime between day 5 and 14 and then rapidly
subsides (Du et al., 2011, 2013). The fundamental question raised
by these observations is whether the neurons in which the virus
replicates differ from those in which the virus remains latent. Is
replication an essential prelude for the establishment of latency?
Latently infected ganglia express a 2.0 and a 1.5 Kb latency
associated transcripts (LATs) derived by splicing from a much
larger transcript (Farrell et al., 1991, Zwaagstra et al., 1990). LATs
appear to be unresolved lariats which may explain their stability
but not the rapid disappearance of the precursor from which they
are derived. In addition to LAT neuronal cells contain a subset of
viral miRNAs (Umbach et al., 2008, Jurak et al., 2010, Sun et al.,
2012). HSV DNA is in heterochromatin structures that enable both
LAT and miRNA precursor RNAs to be synthesized (Wang et al.,
2005, Cliffe et al., 2009, Kristie et al., 2008, Kwiatkowski et al.,
2009, Neumann et al., 2007).
There is a tacit assumption that the failure to express the α genes is
due to the failure of translocation of VP16 and HCF1 to the nucleus of
newly infected neuron. That hypothesis does not explain the observa-
tion that in many neurons the virus does replicate after corneal
inoculation. Another related hypothesis is that transport of VP16 lags
behind that of capsids carrying DNA and that in neurons in which the
virus does replicate the relatively short distance between the site of
inoculation and the neuronal body enables VP16 and associated
proteins to reach the neuron within a time frame necessary to enable
derepression of α genes (La Boissière et al., 1999).
There are 3 fundamental questions regarding the latent state. First,
the question arises as to whether the HCLR complex plays a role in the
formation of viral heterochromatin. To answer this question we
inserted into the wild-type genome an intact REST, a REST fromwhich
the N and C terminal repressor binding sites had been deleted
(dnREST), or a set of stop codons to control for the disruption of viral
DNA sequence at the site of insertion of wild-type or dnREST genes
(Du et al., 2010). The expectations were that if REST plays no role in
the silencing of viral DNA in neurons the dnREST would have little or
no effect on the silencing of viral DNA. If REST is involved in the
establishment of latency, the dnREST would compete with wild-type
REST for RE1 sites and block the binding of repressors that constitute
the HCLR complex. As a consequence there would be fewer neurons
harboring latent virus. The results were unexpected: the dnREST virus
was far more lethal than the wild-type parent (Du et al., 2010). The
signiﬁcance of the results stems from the implication that HSV could
have evolved into a far more virulent virus but did not. An obvious
conclusion stems from the well-established fact that HSV depends on
physical contact of uninfected and infected tissues for transmission.
Incapacitated patients are unlikely to transmit the virus by physical
contact of infected and uninfected tissues. Viruses acquiring mutations
that cause them to become virulent are not likely to be disseminated.
The second and equally signiﬁcant question stems from the
necessary conclusion that dnREST was expressed at least in amounts
sufﬁcient to compete with wild-type REST. To have this effect, the
competition would have to have occurred in neurons on the path to
repress HSV gene expression. Do the data imply that a silent latent
state can be established even after expression of proteins encoded by
the virus?
Finally the ability of the transcriptional machinery of the neuron
to discriminate between the sequence encoding the LAT precursor
RNA and those encoding the transcripts of silenced genes remains a
puzzle. The problem stem from the implied conclusion that the
regulation of expression of the LAT precursor mRNA is independent
from that of other genes. If this were true, it would be expected that
in productively infected cells LAT would be expressed concurrently
with α gene products. In fact, LAT accumulates late in infection sug-
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gesting the possibility that it may require other viral gene products
for its expression.
Activation of silent genome in latently infected neurons
Reactivation of silent genomes in latently infected neurons in vivo
involves two steps. In the ﬁrst, the resident silent DNA initiates the
expression of its gene and infectious particles are assembled.
In the second the infectious particles are transported anterograde
to cells in which they initiate a productive infection (Reviewed in
Roizman et al., 2013). In this step initiation of infection is the result of
entry of virion and its components into uninfected cells and therefore
the course of the infection would be predicted to be not different
from that of virus entering cells at a mucous membrane. To deﬁne
the events of reactivation it is critical to uncouple the two steps of
the reactivation process. The focus of this section is on the ﬁrst step.
It takes place in the absence of either VP16 or ICP0 and the question
posed here is how viral genes become derepressed in the absence of
these proteins and in what order the genes are transcribed.
In principle two models have been described. The ﬁrst involves
heating the mouse for a precise time interval in a water bath (Sawtell
and Thompson, 1992). Our attempts to duplicate this model were
unsuccessful. The mortality was very high and among survivors few
mice exhibited evidence of reactivation. The model we adapted inv-
olved excision of the ganglia and immediate incubation in medium
that contained anti-NGF antibody to accelerate reactivation or both
NGF and EGF to maintain the virus in latent state. Earlier studies have
shown that virus reactivates from neurons harboring latent virus in
the absence of NGF (Wilcox and Johnson 1987; Wilcox et al., 1990).
The problem is that depletion of NGF in excised ganglia is slow: NGF is
made by many different cells. The antibody to NGF accelerates the
depletionwithin a time frame of a single replicative cycle (18–24 h). In
experiments in which ganglia were excised and incubated in medium
containing antiNGF antibody transcripts of representative α, β, γ1 and
γ2 began to accumulate as early as 5 h after excision of the ganglia
(Du et al., 2011). The conclusion that all viral genes were expressed at
the same time independently of each other emerged from the
observation that transcripts of representative α, β, γ1 and γ2 genes
accumulated with the same kinetics in ganglia incubated in medium
containing 100 mg of cycloheximide per ml of medium (Du et al.,
2011). A necessary conclusion of these studies is that sequential order
of gene expression observed during productive infection is at least in
part an artifact imposed by sequential derepression of viral genes. The
studies on ganglionic organ cultures described above raise numerous
questions. Foremost, the basic ﬁnding must be conﬁrmed in an intact
animal model.
The obvious question that plagues these studies is why in this
model all viral genes are expressed at once whereas in productive
infections in cell culture and presumably at the portal of entry the
genes are expressed sequentially. Expression of all genes at once
implies a catastrophic event that cannot be highly productive in terms
of virus yield. Sequential synthesis of regulatory protein, enzymes
involved in viral DNA synthesis and structural proteins is likely to
maximize virus yields whereas simultaneous synthesis of viral DNA
and structural protein is likely to reduce yields. One hypothesis that
could account for the data is that the portal of entry into the body is
doorway to latent infection and also the site of transmission of the
virus from one individual to another. Transmission is enhanced by
frequent reactivations and appearance of virus at the portal of entry.
Thus at the portal of entry the virus requires high yields to insure both
seeding of sensory neurons and a critical mass for transmission of virus
from one individual to another. To insure a high critical mass, at the
portal of entry regulatory and defensive proteins are made ﬁrst, viral
DNA second and ﬁnally the structural proteins that package the DNA
into virions deﬁne the ﬁnal yield. In contrast the desirable amount of
virus in reactivating ganglia should be sufﬁcient for anterograde
transmission and infection of cells at the portal of entry but not so
high as to break through satellite cells and be transmitted to CNS.
The HCLR complex does not appear to play a role in the rea-
ctivation process. Thus wild-type HSV carrying a wild-type REST gene
established latency but the virus did not reactivate on incubation in
medium containing antibody to NGF. Reactivation as measured by
accumulation of viral mRNAs did occur in medium containing cyc-
loheximide. The data support the hypothesis that the HCLR is
involved in the silencing of viral DNA during establishment of latency
but not during reactivation (Zhou et al., 2013).
Finally, concurrent with accumulation of representative α, β, γ1
and γ2 gene transcripts the amounts of LAT and of the viral miRNAs
decreased (Du et al., 2011). This decrease did not take place in
ganglia treated with cycloheximide suggesting that unlike the
accumulation of viral mRNAs the decrease in LAT and miRNAs
required prior protein synthesis. Studies involving Act. D chases
indicated that miRNAs and LAT were intrinsically stable over many
hours and hence the degradation of LAT and of miRNAs is an active
process involving an as yet unidentiﬁed RNase (Du et al., 2011).
The data strengthen the argument that LAT and miRNAs play a role
in maintaining the viral genome in silent state.
Subsequent studies have shown that in ganglia maintained in
medium containing NGF and EGF viral reactivation could be delayed
for at least 36 h. In these ganglia latent HSV was in a dynamic
equilibrium deﬁned by the status of HDAC 1 and 4, and STAT3 and
p300 and the numerous protein (e.g. PI3K, AKT, mTOR, etc.) that in
turn control the functions of these proteins (Du et al., 2013 and
unpublished data).
Concluding remarks
The passage of nearly 40 years since the publication of studies
that described the order of viral gene expression (Honess and
Roizman, 1974, 1975) has not dimed the interest in deﬁning how
HSV expresses its genes during its sojourn in human cells. The
issues raised in this review may be summarized as follows:
HSV has selected for its sojourn in humans replication mucous
membranes as the portal of entry into the body and sensory
neurons in which to persist. To express its genes and replicate the
virus must use cellular functions. The differences in the viral gene
expression in cells at the portal of entry and in sensory neurons
underscore the differences in the genetic environment of these
two cell populations
The silent state observed during latent infection in sensory
neurons cannot be duplicated in cultured cells except by the use of
drugs or deletion of key viral genes (Wigdahl et al., 1984a, 1984b,
Samaniego et al., 1998). Obviously the repression of viral gene
expression seen in cultured cells modeling the initial infection at
the portal of entry into the body bears little resemblance to the
silent genome in latently infected neurons. The silent genome
serves the virus well in that it keeps the viral genome hidden from
the immune system until a propitious time for it to become active.
Conversely the gene expression cascade observed in cultured cells
requires sequential functions expressed by viral genes. No such
requirement has been noted on reactivation of virus from latent state.
As noted earlier in the text, such controls serve the virus well in that
they maximize virus yields-a necessity to enhance the probability of
transmission from person to person. They are effective however at the
portal of entry and not on reactivation from latent state.
Another puzzle is the regulation of LAT and its associated
miRNAs during productive infection and during the latent state.
In productive infection LAT and its miRNAs are expressed late in
infection and at least the miRNAs appear to require prior viral
gene expression for their synthesis (Du et al., 2015). No such requi-
rement is imposed in latently infected ganglia. Does a neuronal
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protein substitute for the viral inducer in the productively infected
cells to enable LAT expression?
Finally, numerous observations hint that HSV has evolved
elaborate mechanisms to preclude tissue damage to the point
where transmission from person to person would be curtailed. For
example the enhanced virulence of a mutant expressing a domi-
nant negative REST incapable of binding CoREST suggests that
REST response elements is to reduce the potential virulence of the
virus. Another relevant observation is that the population of viral
miRNAS expressed during the latent state is similar to that of
accumulating in productively infected cells and generally different
from that emerging during reactivation. Again, one interpretation
of the data is that the miRNAs in productively infected cells and in
latently infected ganglia perform functions to protect the host and
in so doing enhance the long term interaction between the virus
and its host.
Clearly, to understand the nuances of the 3 facets of HSV sojourn in
the human host we must understand the how the different metabolic
and regulatory pathway in the two cell populations interact with and
mold the expression of viral genes. This review, written in celebration
of the 60th anniversary of Virology merely touches the surface of the
many issues that still need to be resolved if we are to fully understand
the multiple facets of HSV infection.
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